Validation of the Spanish Version of the Voice-Related Quality of Life Questionnaire: Psychometric Properties and Clinical Applications
Folia Phoniatrica et Logopaedica · 2024
DOI: 10.1159/000541290 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Folia Phoniatrica et Logopaedica, 2024. Verfasst von Francisco Contreras-Ruston und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cognition, Development and Educational Psychology, University of Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Quality of Life, Dysphonia, Voice Quality, Voice Disorders. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The present study aimed to validate the Voice-Related Quality of Life (V-RQOL), vocal self-assessment questionnaire for Spanish.
Methods
The validation and psychometric properties were developed according to the criteria of the Scientific Advisory Committee of Medical Outcomes Trust (SAC). The Spanish translation for linguistic and cultural adaptation of the V-RQOL was used. The study involved 193 participants, including 90 vocally healthy individuals and 103 patients with voice disorders, to establish validity. To evaluate reliability, the protocol was applied to 40 participants with dysphonia, who answered it twice before the treatment. Then to determine response changes, the responses of 13 dysphonic participants to the V-RQOL for Spanish were analyzed after intervention and then compared to the initial ones. Clinicians contrasted subjects’ V-RQOL results with a perceptual analysis of voice quality using the GRBAS scale. In order to determine sensitivity and specificity cut-off values, tools results were subjected to the receiver operating characteristic curve analysis. The sensitivity was obtained from the experimental group (dysphonic group) and the specificity from the control group (non-dysphonic group).
Results
This version of the V-RQOL questionnaire may be used as part of the standard assessment process of people with voice complaints and as an outcome of treatment efficacy in clinical trials.
Conclusion
A validation of the V-RQOL for Spanish in Chilean population was achieved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cognition, Development and Educational Psychology, University of Barcelona, Barcelona, Spain.
- Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
- Speech-Language Pathology and Audiology Department - Universidad de Valparaíso, San Felipe, Chile.
- Departamento Otorrinolaringología, Pontificia Universidad Católica de Chile, Santiago, Chile.
- Departamento Otorrinolaringología, Hospital Salvador, Santiago, Chile.
- Escuela de Fonoaudiología, Facultad de Odontología y Ciencias de la Rehabilitación, Universidad San Sebastián, Santiago, Chile.
Zitieren
APA
Contreras-Ruston, F., Fuentes, A. R., Velásquez, L. S., Acevedo, K., Gonzalez, N., Meneses, N. L., Napolitano, C., & Guzman, M. (2024). Validation of the Spanish Version of the Voice-Related Quality of Life Questionnaire: Psychometric Properties and Clinical Applications. Folia Phoniatrica et Logopaedica. https://doi.org/10.1159/000541290
Vancouver
Contreras-Ruston F, Fuentes AR, Velásquez LS, Acevedo K, Gonzalez N, Meneses NL, et al. Validation of the Spanish Version of the Voice-Related Quality of Life Questionnaire: Psychometric Properties and Clinical Applications. Folia Phoniatrica et Logopaedica. 2024. doi:10.1159/000541290
BibTeX
@article{ContrerasRuston2024,
author = {Contreras-Ruston, Francisco and Fuentes, Andrés Rosenbaum and Velásquez, Lukas Salfate and Acevedo, Karol and Gonzalez, Nury and Meneses, Norma León and Napolitano, Carla and Guzman, Marco},
title = {Validation of the Spanish Version of the Voice-Related Quality of Life Questionnaire: Psychometric Properties and Clinical Applications},
journal = {Folia Phoniatrica et Logopaedica},
year = {2024},
doi = {10.1159/000541290}
}
EUVIMED